FOX CHRISTINE ANN (Chief Financial Officer) exercised options at MEREO BIOPHARMA GROUP PLC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 9/13/2024ACC: 0000950170-24-106419
Officer· Chief Financial Officer
Since Feb 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60K acquired · 60K disposed
Non-Derivative Transactions1
American Depositary Shares representing Ordinary Shares
Direct
Shares
+60K
Price / share
—
Trade value
—
% of position
104.2%
9/11/2024
57.57K→117.57K
Total
Net shares
+60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 9/11/2024 | M · Option Exercise | +60K | — | — | 104.2% | 57.57K | 117.57K |
| Total | +60K | $0.00 | ||||||
Derivative Transactions1
Performance Based Restricted Stock Unit
Direct
Converts to
American Depository Shares
60K shares
Shares
−60K
Strike price
0
Held after
0.00
Exercisable
—
9/11/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Based Restricted Stock Unit Direct | American Depository Shares60K shares | 9/11/2024 | M · Option Exercise | −60K | 0 | — | 0.00 |